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INTRODUCTION
Although we have used several systems for the evaluation
and the compensation of the physical impairment patients
in Korea, none of them is considered to be good enough to
meet the high standard of requirement of the courts, the medi-
cal community and workers’ compensation authorities (1-3).
Furthermore as these are from other countries, they could not
reflect the condition of Korean people (4). 
In the urinary and reproductive systems of current Korean
welfare act for the disabled, only the patients with hemodial-
ysis or peritoneal dialysis due to chronic renal failure and the
patients with transplanted kidney and the patients with uri-
nary diversions are acknowledged as the disabled (3). A lot of
patients could not get compensatons because the law doesn’t
cover them. Besides, the compensation of the disability requi-
res different forms of medical certificate for each standard with
further inconvenience. 
In the United States of America, there is a scientific guide-
line to the evaluation of permanent impairment, established
by American Medical Association (AMA) (2). Also, new ver-
sion of AMA guideline was published in 2007 (5).
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For the evaluation of the kidney impairment, serum creatinine concentrations or
glomerular filtration rates are mainly used, and the conditions of solitary or trans-
planted kidney and chronic dialysis are also taken into the considerations. Some
symptoms and signs of the chronic renal disability in spite of adequate treatment
add one additional grade. For evaluating bladder and urethral impairment, the cri-
teria include voiding symptoms and signs. The patients with urinary diversions have
impairment grades depending on the alteration of upper urinary tract function. For
penile impairment, the degrees are evaluated using the international index of erec-
tile function, nocturnal penile tumescence and color doppler ultrasonography. For
evaluating impairment of other male reproductive organs, functional and anatomi-
cal changes of these organs, analysis of the semen or hormones and the state of
solitary testis are used as the criteria. For evaluating impairment of female repro-
ductive organs, pregnancy potential, requirement of continuous treatment and the
ability of sexual intercourse are used. Also, degree of impairment is modified accord-
ing to the ages in evaluating female reproductive systems. We have tried to make
this evaluation system objective, scientific, and convenient, but still find it leaving
much to be desired. 
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Therefore, it is about the time we had a new evaluation sys-
tem which is not only scientific and useful, but appropriate
to the culture and condition of Korean people as well. 
The purpose of this report is to describe the resolved cri-
teria of Korean Academy of Medical Sciences (KAMS) com-
mittee on a permanent impairment in urinary and reproduc-
tive systems, in assessing the severity and in determining the
impact of the impairment on the ability to perform daily
activities. But this is a preliminary report. A lot of part can
be revised through future studies.
MATERIALS AND METHODS
In March 2007, KAMS planned a project for new evalua-
tion of permanent impairment for Korean. It organized 11
committees for each organ and asked them to make new sys-
tems on the evaluation of the permanent impairment (6).
The committee of genitourinary system consisted of ten physi-
cians who were recommended by Korean Association of Inter-
nal Medicine, Korean Urological Association and Korean
Society of Obstetrics and Gynecology.
Through two workshops, the members of the committee
were informed of the background, purpose, basic concept and
rating methods of impairment rating guideline. The evalu-
ation systems for the permanent impairment of European
Union, the United States or some countries in Asia (7) were
also reviewed.
Especially, the AMA Guideline 5th edition (4) on the eval-
uation of permanent impairment made a good reference. Also,
6th edition of the AMA Guideline (5) is published in 2007.
Nevertheless, we tried to make our own one which would
accommodate the culture of Korean people.
An impairment is considered permanent when it has reached
Maximal Medical Improvement (MMI); the impairment is
nearly well stabilized and it is unlikely to change in the next
year with or without medical treatment. Furthermore, the
evaluation for the permanent impairment should be done
when a patient reaches MMI. (5)
This evaluation guides for genitourinary system consist of
four parts; upper urinary tract (kidney), lower urinary tract
(bladder & urethra), male reproductive systems including
prostate, and female reproductive systems.
RESULTS
Guideline for evaluation of upper urinary tract impairment
(Table 1)
Kidney plays important roles in excretion of metabolic
waste, acid-base balance, control of blood pressure (BP), and
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Amount of disability
Grade of
impairment Body
impairment 
Organ
impairment 
Description
1 90% 85-100% Serum Cr ≥10 mg/dL or GFR <15 mL/min
In child, serum Cr ≥4 times of normal Cr value of patient’s age or GFR <15 mL/min/1.73 m2
Patient with 2nd grade and persistent symptoms and signs* of chronic renal disorder in spite of 
adequate treatment
Chronic dialysis patient more than 3 months
2 50% 70-85% Serum Cr: 7-10 mg/dL or GFR: 15-30 mL/min 
In child, serum Cr 3-4 times of normal Cr value of patient’s age or GFR of 15-30 mL/min/1.73 m2
Patient with 3rd grade and persistent symptoms and signs* of chronic renal disorder which needs 
continuous observation or treatment
3 30% 55-70% Serum Cr: 4-7 mg/dL or GFR: 30-45 mL/min 
In child, serum Cr 2-3 times of normal Cr value of patient’s age or GFR of 30-45 mL/min/1.73 m2
Patient with 4th degree of disability and persistent symptoms and signs* of chronic renal disorder 
which needs continuous observation or treatment
Renal transplant patient
4 10% 40-55% Serum Cr: 2-4 mg/dL or GFR: 45-60 mL/min  
In child, serum Cr 1.5-2 times of normal Cr value of patient’s age or GFR of 45-60 mL/min/1.73 m2
Unilaterally functioning kidney
Table 1. Guideline for evaluation of upper urinary tract system impairment 
*, Symptoms and signs of chronic renal disability.
1) Uremic pericarditis (more than moderate degree on echocardiography, etc); 2) Bleeding tendency; 3) Uremic neuropathy (confusion, disorientation,
seizure, peripheral neuropathy, etc); 4) Uremic gastroenteritis (nausea, vomiting, uremic fetor, etc); 5) Uremic pruritus; 6) Renal anemia (Hemoglobin ≤10
gm/dL); 7) Malnutrition (Serum albumin <3.0 gm/dL); 8) Severe hypertension (Diastolic blood pressure ≥105 mmHg, Diastolic pressure in child ≥95
percentile of normal diastolic blood pressure of same age; 9) Electrolyte and Acid-base imbalance.
Cr, creatinine; Ccr, Creatinine clearance rate; GFR, glomurular filtration rate.
erythropoietin production. Serum creatinine (Cr) and creati-
nine clearance rate (Ccr) account for renal function and are
useful to measure upper urinary tract function. Renal impair-
ment is evaluated by medical nephrologist and pediatric ne-
phrologist. 
Symptoms and signs
Symptoms and signs of upper urinary tract impairment
are given in Table 1. 
Laboratory findings
Either Serum Cr or Glomerular Filtration Rate (GFR) is
used. Based on optimal results, GFR evaluation method is
assessed by medical and pediatric nephrologists. 
Disorder grade (Table 1)
Disorder is graded by renal function test, kidney transplan-
tation, dialysis etc. 
In case of different results between serum Cr and GFR, the
poorer renal function is selected.
Impairment grade is assessed in MMI because of the pos-
sibility of disease progression or improvement. 
Hemodialysis longer than 3 months due to chronic renal
failure (CRF) is recognized as first grade, and kidney trans-
plantation is recognized as third grade. According to the
function of transplanted kidney, it can be recognized as more
severe grade. 
Patients on hemodialysis reach MMI at 3 months after the
start of the treatment. Patient with kidney transplantation
reaches MMI in 6 months after the surgery. On condition
that there is no rejection symptom and a physician decides
that the kidney function becomes stabilized. When a patient
gets kidney transplantation after hemodialysis, MMI is reached
at 3 month after the beginning of the dialysis and the impair-
ment rating should be done in 6 months after the operation.
When children are evaluated, disability rate is added by
10%.
Guideline for evaluation of lower urinary tract impairment
(Table 2)
Lower urinary tract impairment is evaluated by urologists.
Guideline for lower urinary tract impairment evaluation 
The bladder is a urine reservoir that is voluntarily control-
lable. Normally it permits several hours of urinary retention.
Pathologic conditions within or outside the urinary system
may induce bladder dysfunction. 
In women, the urethra is a urinary passage and has a vol-
untary sphincter, but no circular smooth muscle sphincter.
In men, the urethra has a voluntary sphincter and propul-
sive muscles, and is a passage for urine and seminal ejacula-
tions.
Symptoms and signs
Urinary frequency, dysuria, urinary incontinence, urine
retention, hematuria, pyuria, passage of urinary calculi, supra-
pubic mass, diminished urinary stream, extraneous or ectopic
urinary openings, periurethral masses, etc.
Disorder grade
Grade of lower urinary tract impairment would be deter-
mined according to Table 2. 
Impairment grade is assessed in fixed or stable impairment
without disease progression or improvement. 
The findings of urodynamic study are not considered in
lower urinary tract impairment evaluation.
Guideline for evaluation of male reproductive organ
impairment
The male reproductive organs include the penis, scrotum,
testicles, epididymis, spermatic cords, prostate, and seminal
vesicles. The percentages would be increased by 50% for men
younger than 40 yr, and decreased by 50% for men older
than 65 yr.
The impairment of male reproductive organ impairment
is evaluated by urologists.
Guideline for evaluation of penile impairment (Table 3)
The penis has the sexual functions of erection and ejacula-
tion. Urinary function of the penis is discussed before. When
evaluating the impairment of penis, consider impairment of
both sexual and urinary functions. Impairment of sexual func-
tion would be determined according to Table 4. To deter-
mine impairment of the whole person, this estimate would
be combined with the appropriate percentage for estimated
urinary function impairment. This classification also may
be used to estimate penile implant impairment.
Symptoms and signs
Erection and sensation abnormalities of the penis, partial
or complete loss of the penis, etc.
Disorder grade
Objective techniques useful in evaluating penis function
include, but are not limited to, penile tumescence studies,
doppler ultrasound penile blood flow evaluations, dynamic
cavernosometry, cavernosography and angiography. (8)
Disorder is graded by the degree of vaginal penetration, erec-
tion, ejaculation and orgasm using international index of erec-
tile function (IIEF) questionnaire, nocturnal penile tumes-
cence (NPTM) and color doppler ultrasonography (CDU).
Guideline for evaluation of scrotum impairment (Table 4)
The scrotum covers, protects, and provides a suitable envi-
ronment for the testicles. 
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Amount of disability
Grade of
impairment Body
impairment 
Organ
impairment 
Description
1 30-39% 81-100% Impaired bladder reflex activity with loss of voluntary control on micturition resulting in the use 
permanent urinary diversion (e.g. nephrostomy, ileal conduit, vesicostomy, suprapubic cystostomy
or clean intermittent catheterization)
or
Urethral dysfunction causing intermittent or continuous urine dribbling and loss of voluntary urinary
control resulting in the use permanent urinary diversion (e.g. suprapubic cystostomy or clean
intermittent catheterization)
or 
Urethral dysfunction or change of lower urinary tract system resulting in the use permanent bilateral 
percutaneous nephrostomy
and
Alteration in normal upper urinary tract function is seen directily/indirectly resulting from changes in 
either bladder or urethral function
2 20-29% 51-80% Impaired bladder reflex activity with loss of voluntary control on micturition resulting in the use 
permanent urinary diversion (e.g. nephrostomy, ileal conduit, vesicostomy, suprapubic cystostomy
or clean intermittent catheterization)
or
Urethral dysfunction causing intermittent or continuous urine dribbling and loss of voluntary urinary 
control resulting in the use permanent urinary diversion (e.g. suprapubic cystostomy or clean
intermittent catheterization)
or 
Residual urethral blockage of over 75% upon cystoscopy, urethroscopy or performance of a voiding
cystourethrogram resulting in the use permanent urinary diversion (e.g. suprapubic cystostomy 
or clean intermittent catheterization) despite of operation or any other treatments
or 
Urethral dysfunction or change of lower urinary tract system resulting in the use permanent unilateral
percutaneous nephrostomy
and
Upper urinary tract function is not affected by the bladder disorder
3 10-19% 31-50% Symptoms and signs of bladder disease that require continuous treatment
Normal bladder function is not seen without treatment
or
Urethral dysfunction causing intermittent or continuous urine dribbling and loss of voluntary urinary
control that require continuous treatment but not the use permanent urinary diversion (e.g.
suprapubic cystostomy or clean intermittent catheterization)
or 
Residual urethral blockage of over 50 to 75% upon cystoscopy, urethroscopy or performance of a 
voiding cystourethrogram resulting in the use continuous urethral dilation 
and 
Upper urinary tract function is not affected by the bladder disorder
4 1-5% 0-30% Recurrent symptoms and signs of bladder disease that require intermittent treatment
Normal bladder function is seen during recurrent episodes
or
Urethral dysfunction causing intermittent or continuous urine dribbling and loss of voluntary urinary 
control that require intermittent treatment but not the use permanent urinary diversion (e.g. 
suprapubic cystostomy or clean intermittent catheterization)
or
Residual urethral blockage of 25 to 50% upon cystoscopy, urethroscopy or performance of a voiding
cystourethrogram resulting in the use irregular intermittent urethral dilation 
and 
Upper urinary tract function is not affected by the bladder disorder
Table 2. Guideline for evaluation of lower urinary tract system impairment 
The functional or structural impairment mentioned above should be directly related to the cause which is claimed for.
All description criteria must be met for each category of impairment grade.
Symptoms and signs
Pain or enlargement of scrotum, testicular immobility, inap-
propriate testicle location, testicular masses, etc.
Disorder grade
Objective techniques useful in evaluating scrotum func-
tion include, but are not limited to, observation, palpation,
testicular examination, and scrotal ultrasound. (9)
Disorder is graded by scrotal pain or discomfort, architec-
tural alteration of scrotum, the state of testicular function
and the location of testicle.
Guideline for evaluation of testis, epididymis and spermatic cord
impairment (Table 5)
The testicles produce spermatozoa and synthesize male
steroid hormones. The epididymis and spermatic cords trans-
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Amount of disability
Grade of
impairment Body
impairment 
Organ
impairment 
Description
1 20-25% 41-60% Vaginal insertion is impossible. Degree is severe category in IIEF questionnaire, NPTM, vasoactive
agents induced CDU
2 14-19% 21-40% Vaginal insertion is possible, however there is severe difficulty in normal erection, ejaculation and 
orgasm
Degree is over moderate category in IIEF questionnaire, NPTM, vasoactive agents induced CDU
3 8-13% 0-20% Vaginal insertion is possible, however there is a little difficulty in normal erection, ejaculation and 
orgasm
Degree is mild category in IIEF questionnaire, NPTM, vasoactive agents induced CDU
Table 3. Guideline for evaluation of penile impairment 
Increase the percentages by 50% for men younger than 40 yr old, and decrease the percentages by 50% for men older than 65 yr old.
IIEF, International Index of Erectile Function; NPTM, nocturnal penile tumescence; CDU, Color Doppler ultrasongraphy.
Increase the percentages by 50% for men younger than 40 yr old, and decrease the percentages by 50% for men older than 65 yr old.
Increase the percentages by 50% for men younger than 40 yr old, and decrease the percentages by 50% for men older than 65 yr old.
Amount of disability
Grade of
impairment Body
impairment 
Organ
impairment 
Description
1 11-15% 41-60% Scrotum is entirely lost (over 90%)
2 5-7% 21-40% Scrotum is almost lost (60-89%), the testicular function is normal, however, one testicle was moved 
to outside of the scrotum or removed to preserve testicular function
3 1-3% 0-20% Testicular function is normal, however, location of the testicle is a little changed due to the scrotum 
lost (30-59%)
Table 4. Guideline for evaluation of scrotal impairment 
Amount of disability
Grade of
impairment Body
impairment 
Organ
impairment 
Description
1 13% 41-60% Anatomical change of the testis, epididymis or spermatic cord
The signs and symptoms by disease of related organ remain, but continuous treatment is needed
No Function of semen or hormones 
2 7-12% 21-40% Anatomical change of the testis, epididymis or spermatic cord
The signs and symptoms by diseases of related organ were remained, but continuous treatment 
is needed
Analysis of semen or hormones is in abnormal range
3 1-6% 0-20% Anatomical change of the testis, epididymis or spermatic cord
The signs and symptoms by disease of related organ remain, but continuous treatment is not needed
Analysis of semen or hormones is in normal range
Solitary testicle
Table 5. Guideline for evaluation of testis, epididymis and spermatic cord impairment
port the spermatozoa.  
Symptoms and signs
Local or referred pain, tenderness and change in size, con-
tour, position, and texture, testicular hormones and seminal
fluid abnormalities, size and textural changes, testicular, epi-
didymal, and spermatic cord function disturbances, etc.
Disorder grade
Objective techniques useful in evaluating testicular, epi-
didymal, and spermatic cord function include, but are not
limited to, vasography, ultrasound, spermatic arteriography
and venography, biopsy, semen analysis, and clomiphene stim-
ulation test, gonadotropin releasing hormone (GnRH) stim-
ulation test, and human chorionic gonadotropin stimulation
test (9).
Disorder is graded by testicular symptoms or signs, archi-
tectural alteration of testis, epididymis or spermatic cord, the
need of continuous treatment, analysis of semen or hormone.
The solitary testicle is recognized as third grade.
Guideline for evaluation of prostate and seminal vesicle
impairment (Table 6)
The prostate and seminal vesicles provide the appropriate
nutrition, environment, and transport for spermatozoa and
semen. Impairments associated with urinary functions of the
parts of the urethra involved with the prostate are discussed
in the lower urinary tract system.
Symptoms and signs
Local or referred pain, tenderness, oligospermia, hemosper-
mia, urinary tract abnormalities, etc.
Disorder grade
Objective techniques useful in evaluating prostate and sem-
inal vesicle function include, but are not limited to, urogra-
phy, endoscopy, prostatic ultrasonography, vasography, biopsy,
prostate secretion examination, magnetic resonance imaging
(MRI), and hormone excretion pattern analysis (10). 
Disorder is graded by the function of prostate and seminal
vesicle, symptoms or signs related to prostate and seminal
vesicle disease and the need of continuous treatment.
Sexual dysfunction or urinary incontinence by radical prosta-
tectomy to treat prostatic cancer is recognized as first grade.
Guideline for evaluation of female reproductive organ
impairment 
The female reproductive organs include the vulva, vagina,
cervix, uterus, fallopian tubes, and ovaries. Impairment of
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Amount of disability
Grade of
impairment Body
impairment 
Organ
impairment 
Description
1 15% 41-60% Sexual dysfunction or urinary incontinence by radical prostatectomy to treat prostatic cancer 
2 7-14% 21-40% Abnormal function and anatomical change of prostate and seminal vesicle
Symptoms and signs related with prostate and seminal vesicle are severe and frequent
Continuous treatment is needed
3 1-6% 0-20% Abnormal function and anatomical change of prostate and seminal vesicle is remaining, however, 
continuous treatment is not needed
Table 6. Guideline for evaluation of prostate and seminal vesicle impairment
Amount of disabilityGrade of
impairment Body impairment Description
1 26-35% Loss of bilateral ovarian function before menopause 
pregnancy rate 0% e.g.) Bilateral oophorectomy, ovarian failure due to infection, radiotherapy, chemotherapy, and 
premature menopause
2 16-25% Symptoms and signs of ovulation disorder needs constant treatment
pregnancy rate 40% But, no abnormal findings in laparoscopy and hysterosalpingogram 
3 e.g.) Polycystic ovarian syndrome
0-15% A patient has signs of ovarian disorder or deformation and does not need constant treatment
pregnancy rate 50-100% or
A patient has one ovary which has normal function 
e.g.) Unilateral or bilateral ovarian cystectomy, Unilateral oophorectomy
Table 7. Guideline for evaluation of ovarian impairment
Increase the percentages by 50% for men younger than 40 yr old, and decrease the percentages by 50% for men older than 65 yr old.
The degree of impairment is modified according to age.
female reproductive organs is strongly influenced by ovarian
function which changes with aging. Physiologic changes,
before and after menopause, are very important when evalu-
ating and estimating female reproductive organ impairment.
Guideline for evaluation of fallopian tube and ovary impairment
(Table 7, 8)
The Fallopian tubes transport ova, and spermatozoa. The
ovaries develop and release ova and secrete sex and reproduc-
tive hormones.
Symptoms and signs
Vaginal bleeding or discharge, fallopian tube stenosis or
obstruction, abnormal morphologic characteristics, pelvic
masses or neoplasia, absent, infrequent, or abnormal ovula-
tion, abnormal hormone secretion, menstrual dysfunction,
etc.
Disorder grade
Objective techniques useful in evaluating fallopian tube
and ovarian function include, but are not limited to, cervi-
cal and vaginal cytologic smears, pelvic roentgenography,
hysterosalpingography, ovarian biopsy, blood and urine hor-
monal assays, ultrasonogram, computed tomography, mag-
netic resonance imaging, laparoscopy, and basal body tem-
perature studies.
Disorder is graded by symptoms or signs related to vulva
or vaginal disease, the need of continuous treatment, the pos-
sibility of delivery or sexual intercourse.
The degree of impairment is modified according to age
(Table 9).
Guideline for evaluation of uterus and cervix impairment (Table 10)
The most important function of uterus is to maintain preg-
nancy. Impairment of uterine corpus and cervix may have an
effect on the maintenance of pregnancy. Because maternal age
is also an important factor for pregnancy, it is strongly rec-
ommended to consider in assessing uterine function. In this
part, we excluded fertility disadvantage related to ovarian func-
tion which is shown by menstrual dysfunction. Uterine im-
pairment is confined to organ impairment rate. Diagnostic
tools for assessing uterine impairment are listed in Table 11.
We calculated final uterine impairment by multiplying the
rate of age-related uterine impairment and the rate of disease-
related uterine impairment (Table 12).
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Amount of disabilityGrade of
impairment Body impairment Description
1 26-35% Bilateral tubal agenesis or loss of bilateral tubes before menopause, not restorable by operation
pregnancy rate 0% e.g.) tubal agenesis in Mullerian agenesis, bilateral salpingectomy due to tubal pregnancy
2 26-35% Bilateral tubal occlusion or loss of bilateral tubes before menopause
pregnancy rate 30% Restorable by operation 
e.g.) Bilateral tubal obstruction due to infection, bilateral tubal occlusion following tubal ligation
3 16-25% A patient has signs of tubal deformation and needs constant treatment
pregnancy rate 50% But, tube(s) is (are) patent in laparoscopy and hysterosalpingogram 
e.g.) tubal adhesion, hydrosalpinx
4 0-15% A patient has signs of tubal deformation and does not need constant treatment
pregnancy rate 50-100% or
A patient has one tube which has normal function before menopause 
e.g.) Unilateral salpingectomy due to tubal pregnancy
After chemotherapy in tubal pregnancy treatment
Table 8. Guideline for evaluation of uterine tube impairment
Age (yr) Delivery Sexual function
20-34 100% 100%
35-44 60% 80%
45-50 20% 70%
Above 51 0% 50%
Table 9. Degree of impairment modification according to age
Grade 
of impair-
ment
Organ 
impair-
ment
Body 
impair-
ment
Description
Amount of disability
1 20% 46-100% The impairment of pregnancy potential 
is 46 to 100%
2 9-17% 31-45% The impairment of pregnancy potential 
is 31 to 45%
3 1-7% 15-30% The impairment of pregnancy potential 
is 15 to 30%
4 0% -15% The impairment of pregnancy potential 
is less than 15%
Table 10. Guideline for evaluation of uterine impairment
The degree of impairment is modified according to age.
The degree of impairment is modified according to age.
Symptoms and signs
Women with uterine impairment do not show specific
symptoms and signs. Most of them visit a hospital due to
menstrual dysfunction and infertility. The others are women
who experienced hysterectomy because of uterine myoma or
cancer.  
Disorder grade (Table 10)
Disorder is graded by percentage of pregnancy potential.
Disorder is graded by percentage of pregnancy potential.
If women have more than one morbid conditions of uterus,
the sum of the rate of disease-related uterine impairment is
considered as her total impairment rate. When it exceeds
100%, 100% is considered as her total diseases-related uter-
ine impairment rate. The only exception is a case of hysterec-
tomy. In this case, 100% impairment is assigned regardless
of women’s age. 
If the degree of uterine impairment is changed (for exam-
ple, in cases of hysterectomy, septostomy, or adhesiolysis), it
should be reassessed.
Guideline for evaluation of female external genitalia impairment
(Table 13, 14)
The vulva has cutaneous, sexual, and urinary functions. Uri-
nary function is discussed in the urinary system. The vagina
has a sexual function and also serves as a birth passageway.
The clitoris is an erectile organ that has an important role in
sexual functioning. 
Symptoms and signs
Sensation alteration or loss, lubrication loss, partial or com-
plete absence of vulva and vagina, vulvovaginitis, vulvitis,
vaginitis cicatrization, ulceration, stenosis, atrophy or hyper-
trophy, neoplasia or dysplasia, difficulties with sexual inter-
course, urination, or vaginal delivery, underlying perineal
structure support defect, etc.
Disorder grade
Vulvar and vaginal impairment evaluation is divided into
two guides in terms of delivery or sexual function.
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Amount of disability
Grade of
impairment Organ
impairment
Body
impairment
Description
1 20% 100% Vulvar or vaginal disease or deformity symptoms and signs require continuous treatment
and
Vaginal delivery not possible if premenopausal
2 9-17% 60% Vulvar or vaginal disease or deformity symptoms and signs require continuous treatment
and
Limited potential for vaginal delivery if premenopausal
3 1-7% 30% The impairment of pregnancy potential is less than 15%
Table 13. Guideline for evaluation of vulva and vagina impairment in terms of delivery
The rate of age (year)-related loss of pregnancy potential
The rate of disease-related loss of pregnancy potential
Table 12. The rate of age (year)-related loss of pregnancy poten-
tial and disease-related loss of pregnancy potential
Uterine anomaly
Didelphys: 20%
Unicornuate uterus: 30%
Bicornuate uterus: 20%
Septate uterus: 30%
Arcuate uterus: 20%
Incompetent internal os of cervix: 50%
Uterine synechiae
Mild: 20%
Moderate: 40%
Severe: 80%
Uterine myoma or adenomyosis (at least one of more than 5 cm 
myoma in diameter): 10%
Uterine polyp: 20%
Hysterectomy, total or subtotal: 100%
Age of 20 to 34: 0%
Age of 35 to 39: 20%
Age of 40 to 44: 30%
Age of 45 to 49: 50%
Age of more than 50: 100%
The degree of impairment is modified according to age.
Diseases Diagnostic methods
Congenital anomaly Hysteroscopy (or hysterosalpingography)
and laparoscopy
Incompetent internal os History*
of cervix
Uterine synechiae Hysteroscopy or hysterosalpingography
Myoma Ultrasonography, CT, or MRI
Adenomyosis Ultrasonography, CT, or MRI
Polyp Hysteroscopy
Hysterectomy Reviews of medical records
Table 11. Diagnostic tools for assessing uterine impairment
*, Women experienced at least one pregnancy loss which was related to
painless cervical dilatation during the 2nd or 3rd trimester of pregnancy.
Disorder is graded by symptoms or signs related to vulvar
or vaginal disease, the need of continuous treatment, the pos-
sibility of delivery or sexual intercourse.
The degree of impairment is modified according to age
(Table 9).
DISCUSSION
In the United States, the American Medical Association’s
Guides (4) to the evaluations of permanent impairment have
been developed and are the most commonly used source for
assessing and rating an individual’s permanent impairment.
Even though we referred the AMA’s guideline 5th edition (4)
as a model, we also tried to make our own which would fit
more for Korean people.
Needless to say, the ideal evaluation of impairment should
depend entirely on objective findings of the patients. How-
ever, the reality is different. We just try to use more objective
tools in the evaluation. And physicians could determine the
rating in a comprehensive way using subjective and objective
findings. We are afraid that the determination of the rating
would be somewhat different depending on physicians, espe-
cially in patients with voiding dysfunction and sexual dys-
function.
Evaluation of upper urinary tract system impairment
Originally, the first Korean version of the Guideline to the
Evaluation of Permanent Renal Impairment (11) was based
on the guideline similar to that published by American Med-
ical Association (4). The revised second Korean version of the
Guideline to the Evaluation of Permanent Renal Impairment
offers several following features. 
First, we simplified grading instructions to promote con-
sistent scoring of impairment ratings and to minimize the
bias among physicians. In the previous edition, grading sys-
tem was complex and complicated. 
We unify these three groups (Table 15) into one group
(Table 1) with deleting relatively mild symptoms and signs,
such as edema, hematuria or proteinuria and renal osteodys-
trophy. We also clarified the definition of symptoms and signs,
such as ‘‘renal anemia’’ as hemoglobin ≤10 gm/dL and ‘‘severe
hypertension’’ as diastolic blood pressure ≥110mmHg (12).
We changed methods for measuring renal function to Ccr
and serum Cr level from blood urea nitrogen (BUN), Ccr and
serum Cr level in the previous version. Serum Cr is the most
widely used marker for GFR (13). BUN is affected by state
of hydration, catabolism and liver disease. Ccr is a more accu-
rate measure, however, there are many clinical settings where
a Ccr is not available, and decisions concerning drug dosing
must be based on the serum Cr. A formula that accounts for
age-related decreases in GFR, body weight, and sex and allows
an estimate of Ccr in men has been described by Cockcroft-
Gault (12):
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Amount of disability
Grade of
impairment Organ
impairment
Body
impairment
Description
1 20% 100% Vulvar or vaginal disease or deformity symptoms and signs require continuous treatment
and
Sexual intercourse not possible
2 9-17% 60% Vulvar or vaginal disease or deformity symptoms and signs require continuous treatment
and
Sexual intercourse possible only with some degree of difficulty
3 1-7% 30% Vulvar or vaginal disease or deformity symptoms and signs do not require continuous treatment
and
Sexual intercourse possible
Table 14. Guideline for evaluation of vulva and vagina impairment in terms of sexual function
Table 15. Symptom and signs of chronic renal disability in the
previous guideline 
Group I: severe symptoms and signs
Uremic pericarditis (more than moderate degree on echocardiography)
Bleeding tendency 
Uremic central nervous system abnormality (confusion, disorienta-
tion, seizure) 
Group II: moderate symptoms and signs
Uremic peripheral neuropathy 
Uremic gastroenteritis 
Fluid and Electrolyte imbalance
Renal osteodystrophy on radiologic examination
Renal anemia 
Metabolic acidosis
Severe hypertension 
Uremic pruritus 
Group III: mild symptoms and signs
Persistent hypertension or edema
Persistent microscopic hematuria or proteinuria
The degree of impairment is modified according to age.
Creatinine clearance (mL/min)=
(140-age in year)×lean body weight (kg) 
(×0.85 in women)
plasma creatinine (mg/dL)×72
In children, creatinine clearance can be estimated by Sch-
wartz formula (14):
Creatinine clearance (mL/min/1.73 m2)=κ×height (cm)/
serum creatinine (mg/dL)
(κ: 0.55 for children and adolescent females, 0.7 for ado-
lescent males)
We simplified grading instructions for physicians to judge
grade by either renal dysfunction or symptoms and signs,
but not by both of them.
Second, we extended three grades (Table 16, 17) into four
grades (Table 1) to accommodate diversity of renal impair-
ment. We place chronic dialysis patients into the first grade
and renal transplant patients into the third grade.
Third, we added new guideline for pediatric patients with
permanent renal impairment, because normal serum Cr and
Ccr are different according to age or body surface area of pedi-
atric patients. We also added criteria of severe hypertension
in pediatric patients in ‘‘Symptom and Signs of Chronic Renal
Disability’’ (Diastolic pressure in child ≥95 percentile of nor-
mal diastolic blood pressure of same age). 
Evaluation of lower urinary tract system impairment
We developed a system with special attention paid to the
following points.
First, impairment grades for bladder and urethral dysfunc-
tion is incorporated. This is based on the fact that not all
impairments of the lower urinary tract could be objectively
demonstrated. The sole use of strict objective criteria with
numerical values has a high possibility of masking actual
impairments as normal findings or vice versa. An appropri-
ate combination of both objective and subjective results is
incorporated in deciding the final impairment grade to bet-
ter reflect the actual degree of impairment.  
Second, changes to the upper urinary tract and use of uri-
nary diversions are incorporated in the decision of an impair-
ment grade. 
Third, a number of causes of artifact in cystometry must be
recognized. There are technical issues such as pressure mea-
surement artifacts (the presence of air bubbles, kinked tub-
ing, incorrect placement, migration of the pressure catheters)
and infusion rate artifacts (especially in neurogenic bladder)
and patient-related issues, including lack of cooperation, out-
let incompetence, and vesicoureteral reflux. If the bladder out-
let is incompetent, urine may leak around the filling catheter
and a low bladder compliance may not be diagnosed because
the bladder is never adequately filled (spinal dysraphism, severe
intrinsic sphincter deficiency [ISD] in an older woman, etc)
(15). In this scenario, cystometry may not be the main role
in rating permanent impairment of lower urinary tract sys-
tem. So the findings of urodynamic study are not considered
in lower urinary tract impairment evaluation.
Evaluation of male reproductive system impairment
It is difficult to exactly evaluate the ratio of impairment
of organ function induced by trauma or disease, because all
dysfunctions are not exposed to outside of the body. The im-
pact of erectile dysfunction would be greatly different depend-
ing on age, marital status and occupation, etc. Erectile dys-
function is less important in old ages than in young ages.
For example, the penis is not vital organ and is not needed
at work, but erectile function in young patients who are sex-
ually active is very important. Therefore, in the guideline,
we added the 50% of the score expected in patients under
40 yr old, whereas we substracted the 50% of the score ex-
pected in patients over 65 yr old. We hope that the evalua-
tion of the genital organ impairment should be reevaluated
in the future, since the living standard of Korean people is
getting better.
In the guideline of impairment of genital organ function,
some symptoms and signs are quantitatively evaluated by
medical instruments, laboratory examinations or question-
naires, however, others would not be quantitatively evaluat-
ed by the same tools. Therefore, doctor’s bias may distort the
evaluation. In opposite view, some symptoms and signs are
subjectively made by patients. Nevertheless, doctors can not
deny patient’s symptoms such as erectile dysfunction or orgas-
mic dysfunction. 
Evaluation of female reproductive system impairment
We revised the female reproductive system with special
attention paid on the following points. First, impairment of
female reproductive system function is influenced by age, espe-
cially women in child-bearing age. Therefore, we consider
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Table 17. Degree of renal disability in the previous guideline
1st degree: One or more symptom and signs in Table 15 group I 
and One or more severe renal dysfunction in Table 16
2nd degree: Two or more symptom and signs in Table 15 group II and 
One or more moderate renal dysfunction in Table 16
3rd degree: One or more symptom and signs in Table 15 group III and
One or more mild renal dysfunction in Table 16Ccr, Creatinine clearance; Scr, Serum creatinin; BUN, Blood urea nitro-
gen.
Methods Unit Mild Moderate Severe
Ccr mL/min 20≤Ccr<50 10≤Ccr<20 Ccr<10
Scr mg/dL 4≤Scr<7 7≤Scr<10 10≤Scr
BUN mg/dL 20≤BUN<50 70≤BUN<100 100≤BUN
Table 16. Grading of renal dysfunction in the previous guideline
physiologic differences between premenopausal and post-
menopausal women when evaluating and estimating female
reproductive organ impairment.
Second, we tried to describe pregnancy rate according to
ovarian or uterine diseases.
Third, we tried to express appropriate diagnostic tools to
evaluate uterine impairment.
Fourth, we showed the rate of age-related loss of pregnan-
cy potential and the rate of disease-related loss of pregnancy
potential in terms of uterine impairment. Unlike AMA Guide-
line, therefore, we evaluated uterine impairment according
to pregnancy potential. Fifth, we tried to divide the vulvar
and vaginal impairment, into delivery and sexual function. 
In conclusion, we tried our best to make this evaluation
system objective, scientific, and convenient as much as pos-
sible. Nevertheless, we still find it to be revised much more.
We hope that this would help many patients with impair-
ment as well as doctors who evaluate them in the future.   
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